Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name LY3022855
Trade Name
Synonyms IMC-CS4
Drug Descriptions

LY3022855 (IMC-CS4) is a monoclonal antibody against colony stimulating factor 1 receptor (CSF1R), which potentially induces antibody-dependent cell-mediated cytotoxicity (ADCC) in tumor cells over expressing CSF1R (NCI Drug Dictionary).

DrugClasses CSF1R Antibody 5
CAS Registry Number NA
NCIT ID C96801


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cobimetinib + LY3022855 + Vemurafenib Cobimetinib LY3022855 Vemurafenib 0 1
Cyclophosphamide + GVAX pancreatic cancer vaccine + LY3022855 + Pembrolizumab Cyclophosphamide GVAX pancreatic cancer vaccine LY3022855 Pembrolizumab 0 1
Durvalumab + LY3022855 Durvalumab LY3022855 0 1
LY3022855 LY3022855 0 2
LY3022855 + Tremelimumab LY3022855 Tremelimumab 0 1

Additional content available in CKB BOOST